Literature DB >> 14164485

INCOMPLETE SIMIAN PAPOVAVIRUS SV40. FORMATION OF NON-INFECTIOUS VIRAL ANTIGEN IN THE PRESENCE OF FLUOROURACIL.

J L MELNICK, S E STINEBAUGH, F RAPP.   

Abstract

A study was made of the effects of 5-fluorouracil (FU) and 5-fluorodeoxyuridine (FUDR) on the replication of the simian papovavirus SV40 in cercopithecus monkey kidney cells and on the production of virus antigen by these cells. Both drugs markedly suppressed the production of new infectious virus by SV40-infected cells. Synthesis of viral protein was also markedly suppressed by FUDR, but not by FU. In the presence of FU, infected cells produced large amounts of viral protein which were detected by the fluorescent antibody technique. The antigen was not distributed in a particulate fashion as in untreated cells. Diffuse virus antigen was observed in the nuclei of FU-treated cells, resembling the distribution of antigen near the end of the eclipse period in untreated, infected cultures. This stage of antigen production presumably preceded viral assembly. Virus particles with or without cores were rarely seen with the electron microscope in infected FU-treated cells, although large numbers of SV40 particles were readily visualized in untreated, infected cells. It appears that at least one antigenic protein of this papovavirus is synthesized abundantly in FU-treated cells, but is not assembled into virus shells in the presence of the inhibitor.

Entities:  

Keywords:  ANTIGENS; EXPERIMENTAL LAB STUDY; FLUORESCENT ANTIBODY TECHNIC; FLUORODEOXYURIDINE; FLUOROURACIL; KIDNEY; MICROSCOPY, ELECTRON; MICROSCOPY, FLUORESCENCE; MONKEYS; ONCOGENIC VIRUSES; PHARMACOLOGY; SV40 VIRUS; TISSUE CULTURE; VIRAL PROTEINS; VIRUS CULTIVATION

Mesh:

Substances:

Year:  1964        PMID: 14164485      PMCID: PMC2137840          DOI: 10.1084/jem.119.2.313

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  30 in total

1.  Effect of ultraviolet light on tobacco mosaic virus containing 5-fluorouracil.

Authors:  A BECAREVIC; B DJORDJEVIC; D SUTIC
Journal:  Nature       Date:  1963-05-11       Impact factor: 49.962

2.  Biophysical studies on the nature of the simian papova virus particle (vacuolating SV40 virus).

Authors:  H D MAYOR; R M JAMISON; L E JORDAN
Journal:  Virology       Date:  1963-03       Impact factor: 3.616

3.  Superiority of fluorescein isothiocyanate (Riggs) for fluorescent-antibody technic with a modification of its application.

Authors:  J D MARSHALL; W C EVELAND; C W SMITH
Journal:  Proc Soc Exp Biol Med       Date:  1958 Aug-Sep

4.  Preparation of a semipermanent mounting medium for fluorescent antibody studies.

Authors:  J RODRIGUEZ; F DEINHARDT
Journal:  Virology       Date:  1960-10       Impact factor: 3.616

5.  THE MODE OF ACTION OF 5-FLUOROURACIL AND ITS DERIVATIVES.

Authors:  S S Cohen; J G Flaks; H D Barner; M R Loeb; J Lichtenstein
Journal:  Proc Natl Acad Sci U S A       Date:  1958-10-15       Impact factor: 11.205

6.  Icosahedral models and viruses: a critical evaluation.

Authors:  H D MAYOR; J L MELNICK
Journal:  Science       Date:  1962-08-24       Impact factor: 47.728

7.  Papova virus group.

Authors:  J L MELNICK
Journal:  Science       Date:  1962-03-30       Impact factor: 47.728

8.  The rate of formation of vaccinia deoxyribonucleic acid and vaccinia virus.

Authors:  N P SALZMAN
Journal:  Virology       Date:  1960-01       Impact factor: 3.616

9.  Improvements in epoxy resin embedding methods.

Authors:  J H LUFT
Journal:  J Biophys Biochem Cytol       Date:  1961-02

10.  Localization of antigen in tissue cells; improvements in a method for the detection of antigen by means of fluorescent antibody.

Authors:  A H COONS; M H KAPLAN
Journal:  J Exp Med       Date:  1950-01-01       Impact factor: 14.307

View more
  23 in total

1.  SYNTHESIS OF SV40 TUMOR ANTIGEN DURING REPLICATION OF SIMIAN PAPOVAVIRUS (SV40).

Authors:  F RAPP; T KITAHARA; J S BUTEL; J L MELNICK
Journal:  Proc Natl Acad Sci U S A       Date:  1964-11       Impact factor: 11.205

2.  THE INCORPORATION OF SV40 MATERIAL INTO ADENOVIRUS 7 AS MEASURED BY INTRANUCLEAR SYNTHESIS OF SV40 TUMOR ANTIGEN.

Authors:  F RAPP; J L MELNICK; J S BUTEL; T KITAHARA
Journal:  Proc Natl Acad Sci U S A       Date:  1964-12       Impact factor: 11.205

3.  [THE FORMATION OF INCOMPLETE SV-40 VIRUSES IN THE PRESENCE OF 5-IODO-2'-DESOXYURIDINE].

Authors:  G MAASS; J MUELLER; K NAKANOIN; A VOGT; R HAAS
Journal:  Arch Gesamte Virusforsch       Date:  1965

4.  THE NATURE AND LOCALIZATION OF THE SV 40-INDUCED COMPLEMENT-FIXING ANTIGEN.

Authors:  R V GILDEN; R I CARP; F TAGUCHI; V DEFEND
Journal:  Proc Natl Acad Sci U S A       Date:  1965-03       Impact factor: 11.205

5.  [THE BEHAVIOR OF VIRAL DNA IN 5-BROMODEOXYURIDINE-TREATED CELL CULTURES. I. STUDIES ON HERPESVIRUS FOR THE ANTIGEN PROPERTY AND ON THE ABSORPTION CAPACITY OF THE INFECTIOUS VIRUS].

Authors:  K E SCHNEWEIS
Journal:  Arch Gesamte Virusforsch       Date:  1965

6.  Strand-specific transcription of polyoma virus DNA-early in productive infection and in transformed cells.

Authors:  P Beard; N H Acheson; I H Maxwell
Journal:  J Virol       Date:  1975-01       Impact factor: 5.103

7.  Early cytoplasmic vacuolization of African green monkey kidney cells by SV40.

Authors:  T Miyamura; T Kitahara
Journal:  Arch Virol       Date:  1975       Impact factor: 2.574

8.  The control of SV40 transcription during a lytic infection: late RNA synthesis in the presence of inhibitors of DNA replication.

Authors:  L J Rosenthal; M Brown
Journal:  Nucleic Acids Res       Date:  1977-03       Impact factor: 16.971

9.  Replication in simian cells of defective viruses in an SV40-adenovirus "hybrid" population.

Authors:  J S Butel; F Rapp
Journal:  J Bacteriol       Date:  1966-01       Impact factor: 3.490

10.  Interaction of a simian papovavirus and adenoviruses. I. Induction of adenovirus tumor antigen during abortive infection of simian cells.

Authors:  L A Feldman; J S Butel; F Rapp
Journal:  J Bacteriol       Date:  1966-02       Impact factor: 3.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.